# Effect of Anti CD20 in Pemphigus Desease

> **NCT00213512** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 22 (—)

## Conditions studied

- Pemphigus

## Interventions

- **DRUG:** Mabthera

## Key facts

- **NCT ID:** NCT00213512
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-06
- **Final completion:** 2008-10
- **Target enrollment:** 22 (—)
- **Last updated:** 2013-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213512, "Effect of Anti CD20 in Pemphigus Desease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00213512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*